Articoli con mandati relativi all'accesso pubblico - Tiffany N. SeagrovesUlteriori informazioni
Non disponibili pubblicamente: 2
Fluorescence-activated cell sorting of murine mammary cancer stem-like cell subpopulations with HIF activity
DL Brooks, TN Seagroves
Hypoxia: Methods and Protocols, 247-263, 2018
Mandati: US Department of Defense, US National Institutes of Health
Chromatin Immunoprecipitation of HIF-α in Breast Tumor Cells Using Wild Type and Loss of Function Models
DL Brooks, TN Seagroves
Hypoxia: Methods and Protocols, 67-79, 2018
Mandati: US Department of Defense, US National Institutes of Health
Disponibili pubblicamente: 37
O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway
CM Ferrer, TP Lynch, VL Sodi, JN Falcone, LP Schwab, DL Peacock, ...
Molecular cell 54 (5), 820-831, 2014
Mandati: US National Institutes of Health
Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer
LP Schwab, DL Peacock, D Majumdar, JF Ingels, LC Jensen, KD Smith, ...
Breast Cancer Research 14, 1-25, 2012
Mandati: US National Institutes of Health
The role of melanogenesis in regulation of melanoma behavior: Melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways
A Slominski, TK Kim, AA Brożyna, Z Janjetovic, DLP Brooks, LP Schwab, ...
Archives of biochemistry and biophysics 563, 79-93, 2014
Mandati: US National Institutes of Health
ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models
DLP Brooks, LP Schwab, R Krutilina, DN Parke, A Sethuraman, ...
Molecular cancer 15, 1-19, 2016
Mandati: Swiss National Science Foundation, US National Institutes of Health
mTOR/MYC axis regulates O-GlcNAc transferase expression and O-GlcNAcylation in breast cancer
VL Sodi, S Khaku, R Krutilina, LP Schwab, DJ Vocadlo, TN Seagroves, ...
Molecular Cancer Research 13 (5), 923-933, 2015
Mandati: US National Institutes of Health, Natural Sciences and Engineering Research …
MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers
R Krutilina, W Sun, A Sethuraman, M Brown, TN Seagroves, LM Pfeffer, ...
Breast Cancer Research 16, 1-16, 2014
Mandati: US National Institutes of Health
The oncogene HER2/neu (ERBB2) requires the hypoxia-inducible factor HIF-1 for mammary tumor growth and anoikis resistance
KA Whelan, LP Schwab, SV Karakashev, L Franchetti, GJ Johannes, ...
Journal of Biological Chemistry 288 (22), 15865-15877, 2013
Mandati: US National Institutes of Health
The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis
A Golipour, D Myers, T Seagroves, D Murphy, GI Evan, DJ Donoghue, ...
Cancer Research 68 (10), 3591-3600, 2008
Mandati: US National Institutes of Health, Canadian Institutes of Health Research
Activation of estrogen receptor alpha by decitabine inhibits osteosarcoma growth and metastasis
MA Lillo Osuna, J Garcia-Lopez, I El Ayachi, I Fatima, AB Khalid, ...
Cancer research 79 (6), 1054-1068, 2019
Mandati: US National Institutes of Health
Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression
TM Regan Anderson, DL Peacock, AR Daniel, GK Hubbard, KA Lofgren, ...
Cancer research 73 (18), 5810-5820, 2013
Mandati: Swiss National Science Foundation, US National Institutes of Health
The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer
I Fatima, I El-Ayachi, L Taotao, MA Lillo, R Krutilina, TN Seagroves, ...
PloS one 12 (12), e0189864, 2017
Mandati: US National Institutes of Health, Susan G. Komen
Methylparaben stimulates tumor initiating cells in ER+ breast cancer models
MA Lillo, C Nichols, C Perry, S Runke, R Krutilina, TN Seagroves, ...
Journal of Applied Toxicology 37 (4), 417-425, 2017
Mandati: US National Institutes of Health, Susan G. Komen
BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion
A Sethuraman, M Brown, R Krutilina, ZH Wu, TN Seagroves, LM Pfeffer, ...
Breast Cancer Research 20, 1-17, 2018
Mandati: US National Institutes of Health
Breast tumor kinase (Brk/PTK6) is induced by HIF, glucocorticoid receptor, and PELP1-mediated stress signaling in triple-negative breast cancer
TM Regan Anderson, SH Ma, GV Raj, JA Cidlowski, TM Helle, ...
Cancer research 76 (6), 1653-1663, 2016
Mandati: US National Institutes of Health
Putative role of HIF transcriptional activity in melanocytes and melanoma biology
B Zbytek, DL Peacock, TN Seagroves, A Slominski
Dermato-endocrinology 5 (2), 239-251, 2013
Mandati: US National Institutes of Health
The WNT10B network is associated with survival and metastases in chemoresistant triple-negative breast cancer
I El Ayachi, I Fatima, P Wend, JA Alva-Ornelas, S Runke, WL Kuenzinger, ...
Cancer research 79 (5), 982-993, 2019
Mandati: US National Institutes of Health, Susan G. Komen
Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer
MA Hallett, B Teng, H Hasegawa, LP Schwab, TN Seagroves, ...
Breast Cancer Research 15, 1-11, 2013
Mandati: US National Institutes of Health
SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway
A Sethuraman, M Brown, TN Seagroves, ZH Wu, LM Pfeffer, M Fan
Breast Cancer Research 18, 1-15, 2016
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software